ClinicalTrials.gov
public full text
Public Domain
Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids
The objectives of this study are to estimate the efficacy and safety of the daily administration for 6 months of 5 mg versus 10 mg. A 6 month follow-up of subjects is carried out to estimate how the effects of mifepristone are kept in time. The hypothesis of this study is that both mifepristone doses reduce the volume of the myoma up to 50% in six months treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mifepristone for Treatment of Uterine Fibroids#1163702
- Patient Centered Results for Uterine Fibroids#1170877
- Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata#859187
- Pain Assessment in MToP Up to 7 WA (during 5h After Misoprostol Intake)#825772
- Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization#876404
Record · ID 857158
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive